Targeting of Cdc42 GTPase in regulatory T cells unleashes antitumor T-cell immunity is a research paper published in Journal for ImmunoTherapy of Cancer (2022). On theSindex it has a DataRank of 0.505. It has been cited 28 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.505
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Heart, Lung, and Blood Institute
Grant: R56 HL141499
Cincinnati Children's Hospital Medical Center
Grant: RIP
National Cancer Institute
Grant: R01CA234038
National Cancer Institute
Grant: R50CA211404
National Institute of General Medical Sciences
Grant: R01GM108661
FWCI
1.66
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals